G01N 2333/65
Insulin-like growth factors
Official title: Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
G01N2333/65 (Insulin-like growth factors) appears on 88 US grants and 132 published applications in this corpus.
Search patents in G01N- Granted patents
- 88
- Published applications
- 132
- Assignees
- 92
- Inventors
- 278
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 4 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 0 |
| 2003 | 0 | 5 |
| 2004 | 1 | 4 |
| 2005 | 4 | 7 |
| 2006 | 4 | 6 |
| 2007 | 2 | 3 |
| 2008 | 0 | 5 |
| 2009 | 1 | 3 |
| 2010 | 8 | 4 |
| 2011 | 1 | 7 |
| 2012 | 3 | 9 |
| 2013 | 0 | 5 |
| 2014 | 6 | 6 |
| 2015 | 4 | 8 |
| 2016 | 4 | 11 |
| 2017 | 3 | 5 |
| 2018 | 6 | 2 |
| 2019 | 3 | 5 |
| 2020 | 1 | 3 |
| 2021 | 3 | 3 |
| 2022 | 1 | 6 |
| 2023 | 1 | 6 |
| 2024 | 3 | 5 |
| 2025 | 4 | 9 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- IGF2BP2 inhibitors and uses thereof31 Mar 2026US 12,590,056 B2City of Hope
- Detecting and treating growth hormone deficiency3 Feb 2026US 12,539,293 B2Lumos Pharma, Inc.
- IGFBP7 ratio for HFpEF4 Nov 2025US 12,461,113 B2Roche Diagnostics Operations, Inc.
- Identification and quantitation of insulin-like growth factor-I variants by mass spectrometry11 Feb 2025US 12,222,354 B2Quest Diagnostics Investments Incorporated
- Methods and compositions for diagnosis and prognosis of renal injury and renal failure21 Jan 2025US 12,203,941 B2Astute Medical, Inc.
- Igf2bp2 inhibitors and uses thereof27 Aug 2026US 2026/0250242 A1City of Hope
- Biomarkers for huntington disease stratification, methods and uses thereof13 Aug 2026US 2026/0235626 A1
- Use of n-terminal fragment of igfbp-4 in clinical assessment of heart failure and coronary heart disease2 Jul 2026US 2026/0186001 A1Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Multiple biomarker for cancer diagnosis and use thereof26 Feb 2026US 2026/0055469 A1Maxion Corp.
- Igfbp7 ratio for hfpef5 Feb 2026US 2026/0036597 A1Roche Diagnostics Operations, Inc.
Most cited
By later US patents
- Methods for predicting drug response156US 5,824,467 ACeltrix Pharmaceuticals, Inc. · 1998
- Antibodies to insulin-like growth factor I receptor66US 7,037,498 B2Abgenix, Inc. · 2006
- Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency36US 7,258,864 B2Tercica, Inc. · 2007
- Ligand-mediated immunofunctional hormone binding protein assay method34US 5,593,844 AGenentech, Inc. · 1997
- Antibodies to free IGFBP-134US 5,891,722 ACalifornia Research LLC · 1999